Effects of Endokinin A/B and Endokinin C/D on the antinociception of Endomorphin-1 in mice.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Peptides

• Publication date

  2010-04-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.peptides.2009.12.022PMID 20035812
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of Endokinin A/B and Endokinin C/D on the modulation of pain in mice.

  2010cited by this paper
• Inhibitory action of endomorphin-1 on sensory neuropeptide release and neurogenic inflammation in rats and mice.

  2008cited by this paper
• Leucine at the carboxyl-terminal of endokinins C and D contributes to elicitation of the antagonistic effect on substance P in rat pain processing.

  2007cited by this paper
• Rat/mouse hemokinin-1, a mammalian tachykinin peptide, markedly potentiates the antinociceptive effects of morphine administered at the peripheral and supraspinal level.

  2006cited by this paper
• Intrathecal administration of the common carboxyl-terminal decapeptide in endokinin A and endokinin B evokes scratching behavior and thermal hyperalgesia in the rat.

  2006cited by this paper
• Characterization of the gene structures, precursor processing and pharmacology of the endokinin peptides.

  2006cited by this paper
• Endomorphins interact with tachykinin receptors.

  2005cited by this paper
• Tachykinins regulate the function of platelets.

  2004cited by this paper
• Hemokinins and endokinins

  2004cited by this paper
• Characterization of the endokinins: Human tachykinins with cardiovascular activity

  2003influential reference
• Inhibition of neurokinin‐1–substance P receptor and prostanoid activity prevents and reverses the development of morphine tolerance in vivo and the morphine‐induced increase in CGRP expression in cultured dorsal root ganglion neurons

  2003cited by this paper
• Heterodimerization of Substance P and μ-Opioid Receptors Regulates Receptor Trafficking and Resensitization*

  2003cited by this paper
• Identification, localization and receptor characterization of novel mammalian substance P-like peptides.

  2002cited by this paper
• The Tachykinin Peptide Family

  2002cited by this paper
• The NK1 receptor mediates both the hyperalgesia and the resistance to morphine in mice lacking noradrenaline

  2002cited by this paper
• μ-Opioid Receptors Often Colocalize with the Substance P Receptor (NK1) in the Trigeminal Dorsal Horn

  2000cited by this paper
• Hemokinin is a hematopoietic-specific tachykinin that regulates B lymphopoiesis

  2000cited by this paper
• Tachykinin‐like Peptides and Their Receptors: A Review

  1999cited by this paper
• Altered nociception, analgesia and aggression in mice lacking the receptor for substance P

  1998cited by this paper
• A potent and selective endogenous agonist for the mu-opiate receptor.

  1997cited by this paper
• The mammalian tachykinin receptors.

  1995cited by this paper
• Spinal co-administration of peptide substance P antagonist increases antinociceptive effect of the opioid peptide biphalin.

  1994cited by this paper
• Substance P markedly potentiates the antinociceptive effects of morphine sulfate administered at the spinal level.

  1993cited by this paper
• Met-enkephalin and morphine but not dynorphin inhibit noxious stimuli-induced release of substance P from rabbit dorsal horn in situ.

  1985cited by this paper
• Opioid control of the function of primary afferent substance P fibres.

  1985cited by this paper
• Substance P, injected intrathecally, antagonizes the spinal antinociceptive effect of morphine, baclofen and noradrenaline.

  1984cited by this paper
• Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo

  1980cited by this paper
• Opiate analgesics inhibit substance P release from rat trigeminal nucleus

  1977cited by this paper
• Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse.

  1957cited by this paper

• Substance P receptor signaling contributes to host maladaptive responses during enteric bacterial infection

  2025cites this paper
• Substance P receptor signaling contributes to host maladaptive responses during enteric bacterial infection

  2024cites this paper
• Role of hemokinin-1 in health and disease.

  2017cites this paper
• MCRT, a chimeric peptide based on morphiceptin and PFRTic-NH2, regulates the depressor effects induced by endokinin A/B.

  2016cites this paper
• Pain regulation of endokinin A/B or endokinin C/D on chimeric peptide MCRT in mice.

  2016cites this paper
• New tachykinin peptides and nociception

  2013cites this paper
• Analgesic properties of chimeric peptide based on morphiceptin and PFRTic-amide.

  2012cites this paper
• Effects of endokinin A/B and endokinin C/D on the antinociception properties of hemopressin in mice.

  2012cites this paper
• Preliminary analgesic properties of deltorphin-5-methoxytryptamine chimeric opioid peptides.

  2011cites this paper
• Endogenous opiates and behavior: 2010.

  2011cites this paper
• Effects of endokinin A/B, endokinin C/D, and endomorphin-1 on the regulation of mean arterial blood pressure in rats.

  2011cites this paper
• Subcutaneous injection of endokinin C/D attenuates carrageenan-induced inflammation.

  2010cites this paper